Epigenomic profiling reveals DNA-methylation changes associated with major psychosis J Mill, T Tang, Z Kaminsky, T Khare, S Yazdanpanah, L Bouchard, P Jia, ... The American Journal of Human Genetics 82 (3), 696-711, 2008 | 936 | 2008 |
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial A Tutt, H Tovey, MCU Cheang, S Kernaghan, L Kilburn, P Gazinska, ... Nature medicine 24 (5), 628-637, 2018 | 838 | 2018 |
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 650 | 2013 |
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer SA Eccles, EO Aboagye, S Ali, AS Anderson, J Armes, F Berditchevski, ... Breast Cancer Research 15, 1-37, 2013 | 512 | 2013 |
Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking NS Shenker, S Polidoro, K van Veldhoven, C Sacerdote, F Ricceri, ... Human molecular genetics 22 (5), 843-851, 2013 | 437 | 2013 |
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ... Nature genetics 45 (4), 362-370, 2013 | 423 | 2013 |
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017 | 415 | 2017 |
Microarray-based DNA methylation profiling: technology and applications A Schumacher, P Kapranov, Z Kaminsky, J Flanagan, A Assadzadeh, ... Nucleic acids research 34 (2), 528-542, 2006 | 372 | 2006 |
Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 310 | 2015 |
Common variants at 19p13 are associated with susceptibility to ovarian cancer KL Bolton, J Tyrer, H Song, SJ Ramus, M Notaridou, C Jones, T Sher, ... Nature genetics 42 (10), 880-884, 2010 | 296 | 2010 |
Intra-and interindividual epigenetic variation in human germ cells JM Flanagan, V Popendikyte, N Pozdniakovaite, M Sobolev, ... The American Journal of Human Genetics 79 (1), 67-84, 2006 | 290 | 2006 |
Review of processing and analysis methods for DNA methylation array data CS Wilhelm-Benartzi, DC Koestler, MR Karagas, JM Flanagan, ... British journal of cancer 109 (6), 1394-1402, 2013 | 234 | 2013 |
Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research N Shenker, JM Flanagan British journal of cancer 106 (2), 248-253, 2012 | 221 | 2012 |
DNA methylation as a long-term biomarker of exposure to tobacco smoke NS Shenker, PM Ueland, S Polidoro, K van Veldhoven, F Ricceri, ... Epidemiology 24 (5), 712-716, 2013 | 209 | 2013 |
Localization of the Epstein–Barr virus protein LMP 1 to exosomes J Flanagan, J Middeldorp, T Sculley Journal of General Virology 84 (7), 1871-1879, 2003 | 209 | 2003 |
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer H Shen, BL Fridley, H Song, K Lawrenson, JM Cunningham, SJ Ramus, ... Nature communications 4 (1), 1628, 2013 | 182 | 2013 |
Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk K Brennan, M Garcia-Closas, N Orr, O Fletcher, M Jones, A Ashworth, ... Cancer research 72 (9), 2304-2313, 2012 | 174 | 2012 |
Epigenome-wide association studies (EWAS): past, present, and future JM Flanagan Cancer Epigenetics: Risk Assessment, Diagnosis, Treatment, and Prognosis, 51-63, 2015 | 158 | 2015 |
Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients JM Flanagan, M Munoz-Alegre, S Henderson, T Tang, P Sun, N Johnson, ... Human molecular genetics 18 (7), 1332-1342, 2009 | 157 | 2009 |
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21. 31 J Permuth-Wey, K Lawrenson, HC Shen, A Velkova, JP Tyrer, Z Chen, ... Nature communications 4 (1), 1627, 2013 | 140 | 2013 |